Status:
WITHDRAWN
A Prospective Study to Examine the Effectiveness and Safety of Antivirals in Volunteers Who Receive Short-term Prophylaxis Against Pandemic Influenza
Lead Sponsor:
Kirby Institute
Collaborating Sponsors:
National Health and Medical Research Council, Australia
Conditions:
Pandemic Influenza
Eligibility:
All Genders
Brief Summary
This aim of this project is to evaluate the efficacy of neuraminidase inhibitors as short-term prophylaxis against pandemic influenza infection in people who have close familial contact with the disea...
Detailed Description
The aim of this study is to 1. Describe the effectiveness of short-term prophylaxis against symptomatic pandemic influenza infection 2. Describe the safety of short-term prophylaxis 3. Describe the s...
Eligibility Criteria
Inclusion
- Provision of written informed consent
- Intention to commence or have commenced short-term prophylaxis with a neuraminidase inhibitor in individuals who have been exposed to the pandemic virus
Exclusion
- none
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00640874
Last Update
April 24 2012
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
St Vincent's Hospital
Sydney, New South Wales, Australia, 2010
2
Prince of Wales Hospital
Sydney, New South Wales, Australia, 2031
3
Westmead Hospital
Sydney, New South Wales, Australia, 2145
4
Royal Brisbane Hospital
Brisbane, Queensland, Australia, 4000